IL22RA2 and colitis: Of note, we have observed a discrepancy in genetic and pharmacological TNF inhibition on IL-22BP production: blockade of T cell-derived TNF during established colitis induced tissue repair via the IL-22/IL-22BP axis, while genetic depletion of TNF in T cells did not affect IL-22BP.